Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia

被引：0

作者：

Mayer, Jiri ^{[1
,2
]}

Cicatkova, Petra ^{[1
,2
]}

Kovacova, Lenka ^{[3
]}

Jarosova, Marie ^{[1
,2
]}

Karas, Michal ^{[4
]}

Jindra, Pavel ^{[4
]}

Klamova, Hana ^{[5
]}

Polakova, Katerina Machova ^{[5
]}

Cerna, Olga ^{[6
]}

Cmunt, Eduard ^{[7
]}

Belohlavkova, Petra ^{[8
]}

Zak, Pavel ^{[8
]}

Faber, Edgar ^{[9
]}

Papajik, Tomas ^{[9
]}

Stejskal, Lukas ^{[10
]}

Jeziskova, Ivana ^{[1
,2
]}

Weinbergerova, Barbora ^{[1
,2
]}

Jurcek, Tomas ^{[1
,2
]}

Hornak, Tomas ^{[1
,2
]}

Zackova, Daniela ^{[1
,2
]}

Ransdorfova, Sarka ^{[5
]}

Holzerova, Milena ^{[9
]}

Pavlik, Tomas ^{[3
,11
]}

机构：

[1] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic

[2] Masaryk Univ, Brno, Czech Republic

[3] Inst Hlth Informat & Stat Czech Republ, Prague, Czech Republic

[4] Univ Hosp Plzen, Dept Hematol & Oncol, Plzen, Czech Republic

[5] Inst Hematol & Blood Transfus, Prague, Czech Republic

[6] Univ Hosp Kralovske Vinohrady, Dept Hematol, Prague, Czech Republic

[7] Gen Univ Hosp, Dept Internal Med, Hematol, Prague, Czech Republic

[8] Univ Hosp Hradec Kralove, Dept Internal Med 4, Hematol, Hradec Kralove, Czech Republic

[9] Univ Hosp Olomouc, Dept Hematol Oncol, Olomouc, Czech Republic

[10] Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic

[11] Masaryk Univ, Inst Biostat & Anal, Fac Med, Brno, Czech Republic

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2025年 / 100卷 / 04期

关键词：

additional chromosomal abnormalities; chronic myeloid leukemia; cytogenetics; prognosis; FRONTLINE IMATINIB THERAPY; GIMEMA WORKING PARTY; CML;

D O I：

10.1002/ajh.27608

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：729 / 734

页数：6

共 6 条

[1] Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors [J].

Alhuraiji, Ahmad ;

Kantarjian, Hagop ;

Boddu, Prajwal ;

Ravandi, Farhad ;

Borthakur, Gautam ;

DiNardo, Courtney ;

Daver, Naval ;

Kadia, Tapan ;

Pemmaraju, Naveen ;

Pierce, Sherry ;

Garcia-Manero, Guillermo ;

Wierda, William ;

Verstovsek, Srdan ;

Jabbour, Elias ;

Cortes, Jorge .

AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (01) :84-90

[2] Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progression [J].

Clark, Richard E. ;

Apperley, Jane F. ;

Copland, Mhairi ;

Cicconi, Silvia .

BLOOD ADVANCES, 2021, 5 (04) :1102-1109

[3] Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV [J].

Fabarius, Alice ;

Leitner, Armin ;

Hochhaus, Andreas ;

Mueller, Martin C. ;

Hanfstein, Benjamin ;

Haferlach, Claudia ;

Goehring, Gudrun ;

Schlegelberger, Brigitte ;

Jotterand, Martine ;

Reiter, Andreas ;

Jung-Munkwitz, Susanne ;

Proetel, Ulrike ;

Schwaab, Juliana ;

Hofmann, Wolf-Karsten ;

Schubert, Joerg ;

Einsele, Hermann ;

Ho, Anthony D. ;

Falge, Christiane ;

Kanz, Lothar ;

Neubauer, Andreas ;

Kneba, Michael ;

Stegelmann, Frank ;

Pfreundschuh, Michael ;

Waller, Cornelius F. ;

Spiekermann, Karsten ;

Baerlocher, Gabriela M. ;

Lauseker, Michael ;

Pfirrmann, Markus ;

Hasford, Joerg ;

Saussele, Susanne ;

Hehlmann, Ruediger .

BLOOD, 2011, 118 (26) :6760-6768

[4] Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet [J].

Guilhot, Joelle ;

Baccarani, Michele ;

Clark, Richard E. ;

Cervantes, Francisco ;

Guilhot, Francois ;

Hochhaus, Andreas ;

Kulikov, Sergei ;

Mayer, Jiri ;

Petzer, Andreas L. ;

Rosti, Gianantonio ;

Rousselot, Philippe ;

Saglio, Giuseppe ;

Saussele, Susanne ;

Simonsson, Bengt ;

Steegmann, Juan-Luis ;

Zaritskey, Andrey ;

Hehlmann, Ruediger .

BLOOD, 2012, 119 (25) :5963-5971

[5] Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis [J].

Luatti, Simona ;

Castagnetti, Fausto ;

Marzocchi, Giulia ;

Baldazzi, Carmen ;

Gugliotta, Gabriele ;

Iacobucci, Ilaria ;

Specchia, Giorgina ;

Zanatta, Lucia ;

Rege-Cambrin, Giovanna ;

Mancini, Marco ;

Abruzzese, Elisabetta ;

Zaccaria, Alfonso ;

Grimoldi, Maria Grazia ;

Gozzetti, Alessandro ;

Ameli, Gaia ;

Capucci, Maria Adele ;

Palka, Giandomenico ;

Bernasconi, Paolo ;

Palandri, Francesca ;

Pane, Fabrizio ;

Saglio, Giuseppe ;

Martinelli, Giovanni ;

Rosti, Gianantonio ;

Baccarani, Michele ;

Testoni, Nicoletta .

BLOOD, 2012, 120 (04) :761-767

[6] Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis [J].

Marzocchi, Giulia ;

Castagnetti, Fausto ;

Luatti, Simona ;

Baldazzi, Carmen ;

Stacchini, Monica ;

Gugliotta, Gabriele ;

Amabile, Marilina ;

Specchia, Giorgina ;

Sessarego, Mario ;

Giussani, Ursula ;

Valori, Laura ;

Discepoli, Giancarlo ;

Montaldi, Anna ;

Santoro, Alessandra ;

Bonaldi, Laura ;

Giudici, Giovanni ;

Cianciulli, Anna Maria ;

Giacobbi, Francesca ;

Palandri, Francesca ;

Pane, Fabrizio ;

Saglio, Giuseppe ;

Martinelli, Giovanni ;

Baccarani, Michele ;

Rosti, Gianantonio ;

Testoni, Nicoletta .

BLOOD, 2011, 117 (25) :6793-6800

← 1 →